Evidence map›Paper›PMID 36844532›Full record

ArticleACS omega2023

In Silico Guided Nanoformulation Strategy for Circumvention of

Nazia Hassan, Uzma Farooq, Ayan Kumar Das, Kalicharan Sharma, Mohd Aamir Mirza, Suhail Fatima, Omana Singh, Mohammad Javed Ansari, Asgar Ali, Zeenat Iqbal

Abstract read
In one paragraph

Article in ACS omega, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Nanoscale advances · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Nazia HassanDepartment of Pharmaceutics, School of Pharmaceutical Education & Research (SPER), Jamia Hamdard, New Delhi 110062, India.ORCID https://orcid.org/0000-0001-7264-8103
Uzma FarooqDepartment of Pharmaceutics, School of Pharmaceutical Education & Research (SPER), Jamia Hamdard, New Delhi 110062, India.
Ayan Kumar DasHamdard Institute of Medical Sciences & Research, Jamia Hamdard, New Delhi 110062, India.
Kalicharan SharmaDepartment of Pharmaceutical Chemistry, DPSRU, New Delhi 110017, India.
Mohd Aamir MirzaDepartment of Pharmaceutics, School of Pharmaceutical Education & Research (SPER), Jamia Hamdard, New Delhi 110062, India.ORCID https://orcid.org/0000-0002-5780-7601
Suhail FatimaDepartment of Amraz-E-Niswan Wa Qabalat, School of Unani Medical Education & Research (SUMER), Jamia Hamdard, New Delhi 110062, India.
Omana SinghDepartment of Pharmaceutics, School of Pharmaceutical Education & Research (SPER), Jamia Hamdard, New Delhi 110062, India.
Mohammad Javed AnsariDepartment of Pharmaceutics, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj 16278, Saudi Arabia.ORCID https://orcid.org/0000-0001-9266-7133
Asgar AliDepartment of Pharmaceutics, School of Pharmaceutical Education & Research (SPER), Jamia Hamdard, New Delhi 110062, India.
Zeenat IqbalDepartment of Pharmaceutics, School of Pharmaceutical Education & Research (SPER), Jamia Hamdard, New Delhi 110062, India.ORCID https://orcid.org/0000-0003-2788-9420

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Candidal vulvovaginitis involving multispecies of

Identifiers

PMID36844532
PMCPMC9947946

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.